FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

840405005: Tazemetostat (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2020. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3901912011 Tazemetostat (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3901913018 Tazemetostat en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tazemetostat Is a Substance with enzyme inhibitor mechanism of action false Inferred relationship Existential restriction modifier
Tazemetostat Is a Substance with methyltransferase inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Tazemetostat Has disposition Methyltransferase inhibitor true Inferred relationship Existential restriction modifier
Tazemetostat Is a Antineoplastic agent true Inferred relationship Existential restriction modifier
Tazemetostat Is a Substance with benzamide structure true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing only tazemetostat (medicinal product) Has active ingredient True Tazemetostat Inferred relationship Existential restriction modifier 1
Product containing tazemetostat in oral dose form (medicinal product form) Has active ingredient True Tazemetostat Inferred relationship Existential restriction modifier 1
Product containing tazemetostat (medicinal product) Has active ingredient True Tazemetostat Inferred relationship Existential restriction modifier 1
Product containing only tazemetostat in oral dose form (medicinal product form) Has active ingredient True Tazemetostat Inferred relationship Existential restriction modifier 1
Product containing precisely tazemetostat (as tazemetostat hydrobromide) 200 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Tazemetostat Inferred relationship Existential restriction modifier 1
Tazemetostat hydrobromide Is modification of True Tazemetostat Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start